Europe | Peter Schulte

E.U. passes landmark law to restore 20% of Europe’s degraded land and sea by 2030

By Peter Schulte / February 27, 2024 / Good news links

The European Parliament has approved the Nature Restoration Law – setting a target for the E.U. to restore at least 20% of its land and sea areas by 2030, and all ecosystems in need of restoration by 2050. With over 80% of European habitats in poor shape, the E.U. Nature Restoration Law aims to restore degraded ecosystems in all Member States, help achieve the E.U.’s climate and biodiversity objectives and enhance food security.

79% of Crohn’s disease patients in remission after early intervention

By Peter Schulte / February 25, 2024 / Good news links

Led by researchers from the University of Cambridge, a clinical trial examined the effectiveness of giving the immunotherapy drug infliximab earlier, as soon as possible after diagnosis. They employed what’s called a ‘top-down’ strategy, meaning the drug was given straight after diagnosis regardless of the patient’s symptom severity. They found that this early intervention significantly reduces complications of this often debilitating disease, including the need for surgery by a factor of 10.

U.K. quits treaty that lets fossil fuel firms sue governments over climate policies

By Peter Schulte / February 22, 2024 / Good news links

The U.K. will quit the controversial energy charter treaty (ECT) after efforts to align it with net zero emissions plans failed. The treaty allows fossil fuel investors to sue states for lost profit expectations in an opaque corporate arbitration system set up to protect fossil fuel investors in the former Soviet economies in the 1990s.

Belgian boy becomes first child in the world to be cured of brain stem glioma

By Peter Schulte / February 19, 2024 / Good news links

Brain stem glioma, officially called diffuse intrinsic pontine glioma (DIPG), is rare and lethal, diagnosed in just 300 children annually in the United States. The two-year survival rate is 10%, and no drug is widely available for its treatment beyond radiotherapy. After the boy’s diagnosis, the family traveled to France to take part in a randomized controlled trial. He was randomly assigned the drug everolimus, which he took for more than 5 years with remarkable success.

Colorful ribbons on pink background|Doctor

New drug offers breakthrough in treatment of asbestos-linked cancer

By Peter Schulte / February 15, 2024 / Good news links

Scientists at Queen Mary University of London have developed a drug to treat mesothelioma, a notoriously deadly and hard-to-treat cancer linked to asbestos, in the biggest breakthrough in two decades.
An international trial spanning five countries found that the new drug, ADI-PEG20, cuts off the tumor’s food supply and quadruples three-year survival rates. It is the first of its kind to be successfully combined with chemotherapy in 20 years.

Greece legalizes same-sex marriage

By Peter Schulte / February 15, 2024 / Good news links

Greece has become the first Christian Orthodox-majority country to legalize same-sex marriage. Same-sex couples will now also be legally allowed to adopt children after the 176-76 vote in parliament. Prime Minister Kyriakos Mitsotakis proclaimed “People who have been invisible will finally be made visible around us, and with them, many children will finally find their rightful place.”

E.U. reaches first-ever agreement to eliminate various forms of violence against women

By Peter Schulte / February 9, 2024 / Good news links

The European Union has reached a historic agreement to protect women from different forms of violence, including female genital mutilation, forced marriages, and online harassment. Violence against women and girls is one of the most systematic and common human rights violations globally. According to the European Council, one in three women in Europe has experienced physical or sexual violence and 600,000 have undergone female genital mutilation.

Decarbonization containers turn 78% of marine emissions into limestone in new pilot

By Peter Schulte / February 8, 2024 / Good news links

A remarkable pilot project installed on a 787-ft. container ship has proven it’s possible to capture emissions from the smokestacks of cargo ships with 78% efficiency and convert the CO2 into limestone pebbles, which can be offloaded and sold. London startup Seabound, funded by a US$1.5-million grant from the UK Government, partnered up with global shipping company Lomar to install the carbon capture equipment on one of its older and dirtier-burning ships, a medium-sized vessel capable of carrying more than 3,200 shipping containers.

Wind power overtakes natural gas in the E.U. for first time ever

By Peter Schulte / February 7, 2024 / Good news links

The ⁠European Union saw a record drop in fossil fuel power last year, according to a new analysis by energy think tank Ember. In 2023, coal generation fell by 26%, while gas generation fell by 15%. Along with a record buildout of renewables and a downturn in demand, the decline of fossil fuels led to an unprecedented drop in emissions from generating electricity, which fell by 19%. Now, for the first time, wind power supplies more electricity for Europe than either natural gas or coal.

Novel AI model rapidly determines if an antidepressant will work

By Peter Schulte / February 7, 2024 / Good news links

Amsterdam University Medical Center (UMC) and Radboud UMC researchers have developed an algorithm that, based on patient MRI scans and other data, can determine within a week if a particular antidepressant will, offering faster relief and minimizing often painful and damaging side effects. “This is important news for patients,” said Liesbeth Reneman, Professor of Neuroradiology at Amsterdam UMC. “Normally, it takes six to eight weeks before it is known whether an antidepressant will work.”